Risk Factor Models for Neurodevelopmental Outcomes in Children Born Very Preterm or With Very Low Birth Weight: A

Insights

Predicting long-term neurodevelopmental outcomes for very preterm (VPT) or very low birth weight (VLBW) infants is crucial. However, few existing risk factor models are suitable for clinical use, highlighting a need for better prognostic studies.

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics
  • Clinical Epidemiology

Background:

  • Accurate prediction of long-term outcomes for very preterm (VPT) and very low birth weight (VLBW) infants is essential for clinical care, parental counseling, and intervention evaluation.
  • Existing literature on risk factor models for neurodevelopmental outcomes in VPT/VLBW children is extensive, but few models are designed for routine clinical practice, research, or policy.
  • There is a significant gap in the development and application of validated prognostic models for this vulnerable population.

Purpose of the Study:

  • To systematically review the methodologies and reporting standards of studies developing multivariable risk factor models for neurodevelopmental outcomes in surviving VPT/VLBW children.
  • To identify the strengths and limitations of current research practices in this field.
  • To provide recommendations for future research on risk prediction and prognostic modeling for VPT/VLBW children.

Main Methods:

  • A systematic literature search was conducted across MEDLINE, Embase, and PsycINFO databases.
  • The search covered studies published from January 1, 1990, to June 1, 2014.
  • Identified studies were analyzed for their methodology and reporting quality in developing risk factor models for neurodevelopment.

Main Results:

  • The review identified 78 studies reporting a total of 222 risk factor models.
  • A majority of the analyzed studies presented risk factor analyses not specifically designed for prediction.
  • The findings confirm a scarcity of studies focused on developing prognostic models for long-term outcomes in surviving VPT/VLBW children.

Conclusions:

  • The current body of research demonstrates a critical need for the development of robust prognostic models tailored for clinical use in VPT/VLBW survivors.
  • Improvements in study design, methodology, and reporting are necessary to enhance the reliability and applicability of risk prediction models.
  • Future research should prioritize the creation and validation of predictive models to better guide clinical management and support evidence-based interventions for VPT/VLBW infants.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.1K
Biological Influences on Intelligence01:30

Biological Influences on Intelligence

Intelligence is often thought to be linked to brain size, but the relationship is more complex than that. While brain size does correlate modestly with some abilities, like verbal skills, the connection is weaker for others, such as spatial reasoning. Other factors, like brain structure, also play crucial roles. For instance, despite Einstein's smaller-than-average brain, his parietal cortex, which is involved in spatial reasoning, was 15% wider, suggesting that neural density might matter...
622
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K